Skip to content

ENGN

enGene Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$1.91
+0.00%
Ask drillr

Next report

Analyst consensus

Next report date
Dec 28, 2026
EPS estimate
-$0.46
Revenue estimate

Latest reported

Last report date
Sep 8, 2026
EPS actual
-$0.47
EPS estimate
-$0.43
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
5
EPS misses (12Q)
6
EPS in line (12Q)
0
Avg surprise (4Q)
-2.8%
Revenue beats (12Q)

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$4.00
PT range
$4.00 – $4.00
Analysts
2
1 Buy1 Hold0 Sell
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Sep 8, 2026-$0.43-$0.47Miss -10.16%
Jun 15, 2026-$0.48-$0.43Beat 10.42%
Mar 9, 2026-$0.56-$0.44Beat 21.37%
Dec 22, 2025-$0.55-$0.73Miss -32.73%
Sep 11, 2025-$0.58-$0.57Beat 1.44%
Jun 12, 2025-$0.50-$0.51Miss -2.00%
Mar 10, 2025-$0.37-$0.48Miss -29.73%
Dec 19, 2024-$0.48-$0.34Beat 28.69%
Sep 10, 2024-$0.37-$0.32Beat 13.51%
Jun 14, 2024-$0.26-$0.38Miss -46.15%
Mar 11, 2024-$0.41-$0.46Miss -11.26%
Apr 29, 2023-$0.33

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 28, 2026